Navigation Links
Predicting the future in ovarian cancer
Date:11/14/2007

Kisspeptin and its receptor GPR54 predict a favourable clinical outcome in women with ovarian carcinoma, and are specific for the clear cell carcinoma subtype, research published this week in the online open access journal, BMC Medicine, reveals.

The kisspeptins, a family of peptide hormones, and the receptor GPR54 have previously been associated with anti-metastatic activity in certain human tumours. In this study, researchers have shown that kisspeptin and GPR54 are independent prognostic biomarkers specific for ovarian clear cell carcinoma - the first such markers to be identified.

A research team based at the BC Cancer Agency and Vancouver General Hospital, Vancouver, Canada created a tissue microarray - paraffin blocks which allow numerous tissue samples to be analysed simultaneously - from 518 cases of early-stage ovarian carcinoma. They analysed the samples using antibodies against kisspeptin and the G-protein-coupled receptor GPR54. Cases that showed strong staining for either kisspeptin or GPR54 were scored as positive, the rest negative.

The study revealed that patients who were positive for both kisspeptin and GPR54 had a favourable prognosis as compared to those patients who were negative for both kisspeptin and GPR54 cases - both in terms of disease-specific survival and overall survival. Researchers also found that these molecular markers were significantly associated with the clear cell ovarian carcinomas subtype.

Few prognostic or predictive molecular markers for ovarian cancer exist, yet such markers could be vital for the early diagnosis and management of the disease. The authors propose that in the future, serum kisspeptin levels could provide a means to monitor disease activity, and kisspeptins may even have use as therapeutic agentsin women with ovarian clear cell carcinoma. These possibilities require further research, however.

They write: "We anticipate that the strong association of GPR54 an
'/>"/>

Contact: Charlotte Webber
press@biomedcentral.com
44-020-763-19980
BioMed Central
Source:Eurekalert

1

GOOD

Page: 1 2

Related medicine news :

1. Use of certain lipid measures not more effective in predicting coronary heart disease
2. Blood test takes step toward predicting Alzheimers risk, Stanford researchers find
3. Predicting survival after liver transplantation
4. Campaign for Americas Future Memorandum: Katrina Storm Warning
5. Shipcom Partners With DOKUMENTA for METROs Future Store Initiative
6. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
7. American Heart Association Surgical Supplement Journal Report: Appropriate Hospital Discharge System Can Prevent Future Cardiac Events
8. The Humana Foundation and Libraries for the Future Launch Health Literacy Pilot in Atlanta
9. Divorce foretells childs future care for elderly parent
10. Experts Agree. Ohios Technology Investment Future Looks Bright
11. Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)..., STANFORD, Calif. A new study shows that musc...,s ability to squeeze shut properly. The work, per...at patients with conditions such as gastric reflux... used to strengthen sphincters, which are the band...ur intestinal tract. Weakness in these areas can c...
(Date:12/4/2009)...kville, MD "Why is it that men can be bastards a... Lynn Hecht Schafran. The answer, according to an ... interpretation of facial expressions. , In two ...e sex of a series of faces. In the first study, an...ps (angry expressions) were more likely to be iden...
(Date:12/4/2009)...a response to pressure from federal regulators to ... , FRIDAY, Dec. 4 (HealthDay News) -- The maker...ay presented federal regulators with plans to curb...ceutical companies have been under pressure from U... a way to stop the hundreds of fatal overdoses tha...
(Date:12/4/2009)...er the H1N1 virus will come back during winter isn...(HealthDay News) -- The number of states reporting...e this week -- to 25 from a high of 48 just two we...Meanwhile, the supply of H1N1 swine flu vaccine co...or of the U.S. Centers for Disease Control and Pre...
(Date:12/4/2009)... study found they spurred blood vessel growth afte...hDay News) -- Adult stem cells appear to help repa...e phase 1 study of 53 patients found that stem cel...ew blood vessels in heart tissue damaged by heart ...njections within 10 days of having a heart attack....
Breaking Medicine News(10 mins):Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Are angry women more like men? 2Health News:Makers of Powerful Painkillers Present Safety Plans 2Health News:Swine Flu Continues to Wane 2
...n Kile and David Huang found that two important mo...iscovery is sure //to raise the hope of formulatin...telets stored in blood banks. This will in turn in...potentially life-threatening bleeding. This is cau...
...en a choice of exercising alone, with people young...adults would rather exercise with others in their ... useful insight into the preferences of older exer...uchamp, Ph.D., an assistant professor in the Schoo...
...ut with study results that encourage health care p...nodes// marked by the presence of tumor cells in...is, researchers opine, may be a definite clue to c...is important for determining the prognosis and fut...
...l candidate John Edwards’ wife Elizabeth Edwards h...t cancer. This time it is located in the right rib...IV cancer. Mrs. Edwards, who battled breast ca...ht medical treatment for pain on her left side. Wh...
...hat improving the institutional culture (ethos) of... habits like// smoking, drinking, drug abuse and t...don School of Hygiene and Tropical Medicine's Cent...ng responses to these issues seem to have brought ...
...hursday ruled that all private hospitals, built on...ree of cost both at// their indoor and outdoor fac... While holding free treatment to the poor "oblig...provide free treatment upto 25 percent of their ou...
Other Medicine News:Health News:Improved Platelet Life Span Increases Better Patient Care 2Health News:Exercising With Peers Has Added Appeal 2Health News:Doctors Warned to Keep Track of Tumorous Lymph Nodes 2Health News:Doctors Hopeful for Elizabeth Edwards 2Health News:Improve School Ethos to Combat Teen Evils 2Health News:Private Clinics on Public Land Must Treat Poor Free: Court 2
(Date:12/4/2009)... , TARRYTOWN, N.Y., Dec. 4 /PRNewswire/ ...rand prize winners of Bayer,s "Express Your Simple... Brothers, selected the winning video entries subm...untry. The grand prize is an in-person meeting tod... diabetes like Nick, are: Caleb, age 6, from Danbu...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Fir...ced that the US Food and Drug Administration (FDA)...pine fumarate) Extended Release Tablets as adjunct...s with Major Depressive Disorder (MDD). SEROQUEL X...the FDA to treat both major depressive disorder as...
(Date:12/3/2009)... , ACTON, Mass., Dec. 3 /PRNewswire-FirstC...l-Rom Holdings, Inc. (NYSE: HRC ), today announc...iginal Equipment Manufacturer) business website ...ces the Allen Amatech(TM) brand identity and inclu...with detailed descriptions and design specificatio...
Breaking Medicine Technology:Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Proper Physician Relationship Management Ensures Hospital Stability and Vitality 52767 1Proper Physician Relationship Management Ensures Hospital Stability and Vitality 52767 2Canada Grants PLC Systems First Patent for RenalGuard 28R 29 52762 1Canada Grants PLC Systems First Patent for RenalGuard 28R 29 52762 2Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 4783 1Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 4783 2Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression 4783 3
... The ERATO study,published today in the American H...atients with permanent atrial fibrillation, that d...24 hour ventricular rate, on top of,other rate con...7 beats per,minute (p< 0, 0001) with dronedaro...nt and highly statistically significant. This,rate...
...ial showed prasugrel substantially reduced, risk o...clopidogrel among ACS patien...nts who were,diabetic and diagnosed with acute cor...to suffer a heart attack if they were treated with...up analysis of the TRITON-TIMI 38,trial (8.2 perce...
Other Medicine Technology:American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 2American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 2Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 3Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 4Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel 5
ManuTrain
... combines the therapeutic benefits of controlled c...and cold to minimize pain. The versatile design of... hand coverage. ,For added support, support bars ... a wider range of motion is desired.,All Cryo/Cuf...
Cindy Wrist Support
...nel Splint immobilizes and positions the elbow at ...tricts full extension and flexion to minimize stre...and irritation due to contracture. Also for ulnar ...high-density beige polyethylene shell with plush 3...
Medicine Products: